Nkarta NKTX
NASDAQ NKTX
$2.66 +0.19 (+7.69%)
At close: Aug 21, 2026 · 4:00 PM EDT

Nkarta (NKTX) Interest & Investment Income (2019 - 2026)

Nkarta (NKTX) posted quarterly Interest & Investment Income of $2.8 million for Q1 2026, down 35.15% year-over-year from $4.4 million in Q1 2025, and down 13.9% quarter-over-quarter from $3.3 million in Q4 2025.

Nkarta (NKTX) Interest & Investment Income (2019 - 2026) Analysis & Trends

Nkarta's Interest & Investment Income history runs 8 years deep, the most recent figure standing at $2.8 million for Q1 2026.

  • In Q1 2026, Interest & Investment Income fell 35.15% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $14.0 million (down 31.75% YoY), while the FY2025 annual figure was $15.5 million, down 19.79% from the prior year.
  • Interest & Investment Income for Q1 2026 stood at $2.8 million, down from $3.3 million in the prior quarter.
  • The five-year high for Interest & Investment Income was $5.7 million in Q2 2024, with the low at $112000.0 in Q1 2022.
  • The 5-year median for Interest & Investment Income is $3.5 million (2023), against an average of $3.4 million.
  • The sharpest annual moves came in 2023 and 2026: Interest & Investment Income surged 2993.75% in 2023, then slumped 35.15% in 2026.
  • Nkarta's Interest & Investment Income stood at $2.9 million in 2022, then increased by 19.58% to $3.5 million in 2023, then surged by 41.61% to $4.9 million in 2024, then plunged by 32.65% to $3.3 million in 2025, then decreased by 13.9% to $2.8 million in 2026.
  • Business Quant data shows NKTX's Interest & Investment Income at $2.8 million in Q1 2026, $3.3 million in Q4 2025, and $3.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 67.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 27.90 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 28.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 115.94 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 10.98 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 5.13 Mn
10 Nkarta 201.14 Mn 201.14 Mn - 2.54 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.54 Mn
Mar 31, 2026 2.84 Mn
Dec 31, 2025 3.30 Mn
Sep 30, 2025 3.85 Mn
Jun 30, 2025 3.97 Mn
Mar 31, 2025 4.38 Mn
Dec 31, 2024 4.89 Mn
Sep 30, 2024 5.45 Mn
Jun 30, 2024 5.72 Mn
Mar 31, 2024 3.25 Mn
Dec 31, 2023 3.46 Mn
Sep 30, 2023 3.62 Mn
Jun 30, 2023 3.57 Mn
Mar 31, 2023 3.47 Mn
Dec 31, 2022 2.89 Mn
Sep 30, 2022 1.90 Mn
Jun 30, 2022 686,000.00
Mar 31, 2022 112,000.00
Dec 31, 2021 -448,000.00
Sep 30, 2021 81,000.00